Insulin resistance-related gene polymorphisms and risk of prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 6, 2007, Pages 1315-1317

  Moore, Steven C ^a,c,h   Leitzmann, Michael F ^a   Weinstein, Stephanie J ^a   Snyder, Kirk ^b   Albanes, Demetrius ^a   Virtamo, Jarmo ^d   Graubard, Barry I ^a   Mayne, Susan T ^c   Yu, Herbert ^c   Peters, Ulrike ^e,f   Gunter, Marc J ^a,g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; DNA POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RECEPTOR, INSULIN; RISK FACTORS;

EID: 34250902527     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0191     Document Type: Article

References (23)

1. Hsing AW, Gao YT, Chua S, Jr., Deng J, Stanczyk FZ. Insulin resistance and prostate cancer risk. J Natl Cancer Inst 2003;95:67-71.
2. Hsing AW, Chua S, Jr., Gao YT, et al. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 2001;93:783-9.
3. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003;35:694-704.
4. Qian H, Hausman DB, Compton MM, et al. TNFα induces and insulin inhibits caspase 3-dependent adipocyte apoptosis. Biochem Biophys Res Commun 2001;284:1176-83.
5. Hammarsten J, Hogstedt B. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer. Blood Press 2004;13:47-55.
6. Laukkanen JA, Laaksonen DE, Niskanen L, Pukkala E, Hakkarainen A, Salonen JT. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev 2004;13:1646-50.
7. Le Stunff C, Fallin D, Schork NJ, Bougneres P. The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity. Nat Genet 2000;26:444-6.
8. Clausen JO, Hansen T, Bjorbaek C, et al. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 1995;346:397-402.
9. Hitman GA, Hawrami K, McCarthy MI, et al. Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease. Diabetologia 1995;38:481-6.
10. Hart LM, Stolk RP, Heine RJ, Grobbee DE, van der Does FE, Maassen JA. Association of the insulin-receptor variant Met-985 with hyperglycemia and non-insulin-dependent diabetes mellitus in the Netherlands: a population-based study. Am J Hum Genet 1996;59:1119-25.
11. Ho GY, Melman A, Liu SM, et al. Polymorphism of the insulin gene is associated with increased prostate cancer risk. Br J Cancer 2003;88:263-9.
12. Neuhausen SL, Slattery ML, Garner CP, Ding YC, Hoffman M, Brothman AR. Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk. Prostate 2005;64:168-74.
13. Claeys GB, Sarma AV, Dunn RL, et al. INSPstI polymorphism and prostate cancer in African-American men. Prostate 2005;65:83-7.
14. Albanes D, Heinonen OP, Taylor PR, et al. α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70.
15. Heinonen OP, Huttunen JK, Albanes D, et al. Effect of vitamin-E and β-carotene on the incidence of lung-cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
16. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J. The Finnish Cancer Registry as follow-up source of a large trial cohort - accuracy and delay. Acta Oncol 2002;41:381-8.
17. Beahrs OH, Henson DE, Hutter RVP. American Joint Committee on Cancer staging manual. Philadelphia: Lippincott; 1992.
18. Packer BR, Yeager M, Staats B, et al. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 2004;32:D528-32.
19. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
20. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995;12:921-7.
21. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279-84.
22. Bennett ST, Wilson AJ, Cucca F, et al. IDDM2-VNTR- encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J Autoimmun 1996;9:415-21.
23. Li L, Cicek MS, Casey G, Witte JS. No association between genetic polymorphisms in insulin and insulin receptor substrate-1 and prostate cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2462-3.